Alzheimer's disease is the most prevalent neurodegenerative disorder in the elderly. A recent study from the Bloomberg School of Public Health recently estimated that over 26 million people were living with the disease in 2006 and that the global prevalence of the disease will grow to 106 million by 2050. By that time, 43 per cent of those living with the disease will need high-level care, equivalent to that of a nursing home. However, even if modest advances in preventing or delaying the disease's progression were made, it ...
Read More
Alzheimer's disease is the most prevalent neurodegenerative disorder in the elderly. A recent study from the Bloomberg School of Public Health recently estimated that over 26 million people were living with the disease in 2006 and that the global prevalence of the disease will grow to 106 million by 2050. By that time, 43 per cent of those living with the disease will need high-level care, equivalent to that of a nursing home. However, even if modest advances in preventing or delaying the disease's progression were made, it could have a huge impact on global public health. According to this study, interventions that could delay the onset of the disease by as little as one year would reduce the prevalence of the disease by 12 million fewer cases in 2050. These figures reinforce how important it is to find an effective intervention for Alzheimer's disease. Emerging Drugs and Targets for Alzheimer's Disease collects some of the most outstanding examples of new drugs currently under pharmaceutical development or new targets in the validation process that will reach the Alzheimer's drug market over the next few years as disease modifying drugs. Written by a team of distinguished experts, these volumes are an essential resource for scientists in the pharmaceutical and biotechnology industries and academics working in the neurosciences field.
Read Less
Add this copy of Emerging Drugs and Targets for Alzheimer's Disease: to cart. $13.18, like new condition, Sold by Phatpocket Limited rated 4.0 out of 5 stars, ships from Waltham Abbey, ESSEX, UNITED KINGDOM, published 2010 by Royal Society of Chemistry.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Like New. Used-Like New. Book is new and unread but may have minor shelf wear. Ships from UK in 48 hours or less (usually same day). Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. 100% money back guarantee. We are a world class secondhand bookstore based in Hertfordshire, United Kingdom and specialize in high quality textbooks across an enormous variety of subjects. We aim to provide a vast range of textbooks, rare and collectible books at a great price. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions. We provide a 100% money back guarantee and are dedicated to providing our customers with the highest standards of service in the bookselling industry.
Add this copy of Emerging Drugs and Targets for Alzheimers Disease: to cart. $42.74, new condition, Sold by discount_scientific_books rated 4.0 out of 5 stars, ships from Sterling Heights, MI, UNITED STATES, published 2010 by Royal Society of Chemistry.
Add this copy of Emerging Drugs and Targets for Alzheimer's Disease: to cart. $48.87, good condition, Sold by Anybook rated 5.0 out of 5 stars, ships from Lincoln, UNITED KINGDOM, published 2010 by Royal Society Of Chemistry.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
This is an ex-library book and may have the usual library/used-book markings inside. This book has hardback covers. In good all round condition. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item, 700grams, ISBN: 9781849730631.
Add this copy of Emerging Drugs and Targets for Alzheimer's Disease to cart. $49.38, new condition, Sold by Media Smart rated 4.0 out of 5 stars, ships from Hawthorne, CA, UNITED STATES, published 2010 by Royal Society of Chemistry RSC.
Add this copy of Emerging Drugs and Targets for Alzheimer's Disease: to cart. $60.35, good condition, Sold by Bonita rated 4.0 out of 5 stars, ships from Newport Coast, CA, UNITED STATES, published 2010 by Royal Society of Chemistry.
Add this copy of Emerging Drugs and Targets for Alzheimers Disease to cart. $85.33, good condition, Sold by Books International rated 4.0 out of 5 stars, ships from Toronto, ON, CANADA, published 2010 by Royal Society of Chemistry.
Add this copy of Emerging Drugs and Targets for Alzheimer's Disease: to cart. $91.00, new condition, Sold by discount_scientific_books rated 4.0 out of 5 stars, ships from Sterling Heights, MI, UNITED STATES, published 2010 by Royal Society of Chemistry.
Add this copy of Emerging Drugs and Targets for Alzheimer's Disease: to cart. $94.60, new condition, Sold by Bonita rated 4.0 out of 5 stars, ships from Newport Coast, CA, UNITED STATES, published 2010 by Royal Society of Chemistry.
Add this copy of Emerging Drugs and Targets for Alzheimer's Disease: to cart. $177.08, new condition, Sold by Ingram Customer Returns Center rated 5.0 out of 5 stars, ships from NV, USA, published 2010 by Royal Society of Chemistry.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
New. Print on demand Glued binding. Cloth over boards. 342 p. Contains: Line drawings, black & white, Tables, black & white, Figures, Charts. Drug Discovery, 2.
Add this copy of Emerging Drugs and Targets for Alzheimer's Disease: to cart. $200.05, new condition, Sold by Booksplease rated 4.0 out of 5 stars, ships from Southport, MERSEYSIDE, UNITED KINGDOM, published 2010 by Royal Society of Chemistry.
